RBR-108fyykd尚未招募不适用
Safety, effectiveness and duration of immunity after vaccionation against new SARS-COV2 in patients with immunomediated rheumatic diseases
niversidade Federal de São Paulo0 个研究点开始时间: 2021年4月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18Y 至 0（—）
入选标准
- •rheumatoid arthritis; systemic lupus erythematosus; Sjogren's syndrome; systemic sclerosis; myopathies; vasculitis; spondyloarthritis; both sexes; age above eighteen years; medical indication to vaccinate against covid-19
排除标准
- •Immunosuppressed by other causes; HIV; CD4 below two hundred cells; organ transplantation; primary immunodeficiency; cancer; myasthenia gravis; thymoma; absence or surgical removal of the thymus; pregnancy; history of severe adverse reaction to any vaccine previously administered
研究者
相似试验
已完成
3 期
Durability of Immunogenicity and Effectiveness of the heterologous COVID-19 vaccination in kidney transplant recipientsImmunogenicity of the vaccineEffectiveness of the vaccinehumoral immunity, cell-mediated immunity, SARS-CoV-2, immunization, immunocompromisedTCTR20220511002ational Council Researach of Thailand100
进行中（未招募）
1 期
A Long-Term Safety and Immunogenicity Follow-up of Healthy Adults Vaccinated with One Dose of Smallpox Vaccine (LISTER Strain).Five year follow-up of healthy adults already vaccinated in a previous trialEUCTR2006-000715-19-FRSanofi Pasteur SA230
尚未招募
1 期
Safety, preliminary efficacy and immunogenicity of traditional Chinese medicine miRNA hydrogel in the treatment of eczema: a randomized, double-blind, placebo-controlled, dose-increasing clinical studyeczemaITMCTR2000003604Shanghai Skin Disease Hospital
已完成
不适用
A study for safety evaluation and immune effect of excess consumption of plant extract for 4 weeks.Healthy adultJPRN-UMIN000030702CPCC Company Limited12
已完成
1 期
Investigating of the Immunogenicity and Safety of Lactococcus Lactis Vaccine Related to Human Papillomavirus Type 16IRCT20190504043464N1Iran University of Medical Sciences200